This analysis identified several key gene targets that dehydrovomifoliol might influence in the context of leukemia, including TNF, AKT1, IL6, ALB, HSP90AA1, EGFR, ESR1, MAPK3, CASP3, and SRC (Fig. S5). Here, SRC is linked to leukemia.